Home/Store/Medicines from European countries
Sporanox (Itraconazole) 100 mg 30 capsules by Janssen-Cilag — product pack

Sporanox (Itraconazole) 100 mg 30 capsules

€123
Itraconazole 100 mg, 30 oral capsules — triazole antifungal for superficial and systemic mycoses
In stock
Share this product with your friends
ShareSharePin it
Sporanox (Itraconazole) 100 mg 30 capsules
Product Details

Sporanox 100 mg is a prescription antifungal medicine in the form of oral capsules containing itraconazole, a triazole antifungal. It is used for certain fungal infections of the skin, the eye and internal organs, and it must be prescribed and monitored by a doctor. This is a French-market pack of 30 capsules marketed by Janssen-Cilag.

Product overview

  • Trade name: Sporanox 100 mg, gélule
  • Active ingredient: itraconazole 100 mg per capsule
  • Strength: 100 mg
  • Dosage form: hard capsule for oral use
  • Pack size: box of 30 capsules (aluminium-PVC/PE/PVDC blister)
  • Marketing authorisation holder: Janssen-Cilag, 167 quai de la Bataille de Stalingrad, 92130 Issy-les-Moulineaux, France
  • Manufacturer: Janssen Cilag S.p.A., Via C. Janssen, 04100 Borgo San Michele, Latina, Italy
  • Country: France (French market pack, manufactured in Italy)
  • Product category: antifungal for systemic use, triazole derivative
  • Notable excipient: sucrose

What itraconazole is used for

According to the French summary of product characteristics, Sporanox capsules are indicated for:

  • Superficial mycoses: fungal keratitis (including Aspergillus), pityriasis versicolor, and cutaneous dermatophytoses — including heavily keratinised areas such as athlete's foot (tinea pedis) and tinea manus of the palm — when these infections cannot be treated locally because of the extent of the lesions or resistance to the usual antifungals.
  • Systemic or visceral mycoses: inoperable symptomatic aspergilloma; bronchopulmonary and necrotising pulmonary aspergillosis, including in immunocompromised patients; invasive aspergillosis in immunocompromised patients; chromoblastomycosis; histoplasmosis; paracoccidioidomycosis; sporotrichosis and other rare mycoses caused by sensitive organisms.

The efficacy of itraconazole has not been established in nail fungal infection (onychomycosis).

How to use

The dose is set by the doctor. The French labelling gives the following regimens: fungal keratitis — 2 capsules (200 mg) once a day for 21 days; pityriasis versicolor — 2 capsules (200 mg) once a day or 1 capsule (100 mg) twice a day for 5-7 days; cutaneous dermatophytosis — 1 capsule (100 mg) once a day for 15 days or 2 capsules (200 mg) once a day for 7 days; dermatomycoses of heavily keratinised areas — 1 capsule (100 mg) once a day for 30 days or 2 capsules (200 mg) twice a day for 7 days. Systemic mycoses: 2 to 4 capsules a day, with the higher doses used in immunocompromised patients, for several months depending on the infection.

  • Capsules are swallowed whole, without opening them.
  • Take them immediately after a meal, preferably as a single daily dose.
  • Do not stop or change the course without medical advice — in skin infections the best clinical response may only appear 2-4 weeks after the end of treatment.

Possible side effects

The most frequently reported side effects are headache, abdominal pain and nausea. The most serious ones include severe allergic reactions, congestive heart failure and pulmonary oedema, pancreatitis, severe liver injury (including cases of fatal acute liver failure) and severe skin reactions. Other reported effects include dizziness, taste disturbance, peripheral neuropathy, temporary or permanent hearing loss, tinnitus, visual disturbances, raised triglycerides, low potassium, leucopenia and thrombocytopenia.

Important precautions

Sporanox is contraindicated in case of hypersensitivity to itraconazole or to any excipient, in patients with demonstrated ventricular dysfunction such as congestive heart failure or a history of it (unless the infection is severe or life-threatening), and during pregnancy for conditions that do not threaten life. Women of childbearing potential must use effective contraception during treatment and until the onset of the period following the last dose. Itraconazole is a strong inhibitor of CYP3A4 and must not be combined with a number of medicines (for example ergot alkaloids and other listed CYP3A4 substrates) because of the risk of serious, potentially fatal arrhythmias. Tell your doctor about every medicine you take, and mention liver or heart problems, pregnancy or breastfeeding.

Storage

Shelf life 3 years. Keep at a temperature not exceeding 30 °C. Keep out of the sight and reach of children.

Important notice

The photo is provided for identification purposes; packaging design and leaflet text may differ slightly between batches and markets. This information does not replace the advice of a doctor or pharmacist. Sporanox is a prescription medicine and is not a substitute for prescribed treatment.

📦 Ask about availability and delivery to your country on WhatsApp

Show More
You May Also Like
Konaqueen 150 fluconazole 150 mg tablets by Kachhela Medex - product pack, 100 tablets
Konaqueen 150 (Fluconazole) 150 mg 100 tablets
Konaqueen 150 (Fluconazole) 150 mg 100 tablets
Fluconazole 150 mg, 100 tablets — prescription antifungal (triazole)
€55
Triderm (Betamethasone + Gentamicin + Clotrimazole) 0.05% + 0.1% + 1% 15 g cream by Bayer — product pack
Triderm (Betamethasone + Gentamicin + Clotrimazole) 0.05% + 0.1% + 1% 15 g cream
Triderm (Betamethasone + Gentamicin + Clotrimazole) 0.05% + 0.1% + 1% 15 g cream
Betamethasone 0.05% + gentamicin 0.1% + clotrimazole 1%, 15 g cream — triple-combination topical (corticosteroid + antibiotic + antifungal) for infected dermatoses, eczema and dermatomycoses (supplied from Belarus)
€23
  • My Account
  • Track Orders
  • Shopping Bag
Display prices in:EUR
Skip to main content
APV pharma company
Catalog
Payment and delivery
Contacts
How to place an order
ENRU
Menu
Language:
ENRU
Report Abuse
Powered by Lightspeed